UVR-sensor wearable device intervention to improve sun behaviors and reduce sunburns in melanoma survivors: study protocol of a parallel-group randomized controlled trial

Rachel I Vogel, Rebekah H Nagler, Rehana L Ahmed, Katherine Brown, Xianghua Luo, Brian C Martinson, DeAnn Lazovich, Rachel I Vogel, Rebekah H Nagler, Rehana L Ahmed, Katherine Brown, Xianghua Luo, Brian C Martinson, DeAnn Lazovich

Abstract

Background: Individuals who have been diagnosed with melanoma have more than a 9-fold increased risk of developing another melanoma. Ultraviolet radiation (UVR) exposure following a melanoma diagnosis can be modified to reduce risk of a new melanoma diagnosis. Yet research shows that many melanoma survivors do not report optimal sun protection practices. The objective of this study is to evaluate the effectiveness of a UVR-sensor wearable device to improve sun protection behaviors and reduce sunburns in a randomized controlled trial (RCT) in melanoma survivors.

Methods: We will conduct an RCT among 368 melanoma survivors in two waves (Summer 2020, Summer 2021). This approach allows for adequate recruitment of the required sample and potential improvements to recruitment, compliance, and retention strategies between waves. The intervention includes an informational brochure about sun protection behaviors and a commercially available UVR-sensor wearable device (Shade), which accurately measures UVR. The device, along with its associated mobile application, measures and stores UVR exposure. As UVR exposure accumulates, the device provides notifications to increase sun protection action. Survivors in the control group receive the device and a separate mobile application that does not provide notifications or summary UVR exposure data. Participants will be asked to wear the device for 12 weeks. They will complete surveys about their sun behaviors at study entry, every 4 weeks during the intervention, and 1 year later. At the end of the intervention period, intervention and control groups will be compared for differences in a summary measure of sun protection habits and experience of a sunburn. We will also measure self-reported physical activity, depression, and anxiety to examine potential unintended negative consequences of the intervention.

Discussion: The study intervention will be completed Fall 2021, with anticipated results available in 2022. If this intervention improves sun protection behaviors in melanoma survivors, these findings would support expanding the use of this technology with other populations at high risk for melanoma.

Trial registration: ClinicalTrials.gov NCT03927742 . Registered on April 15, 2019.

Keywords: Cancer survivors; Ecological momentary intervention; Melanoma; Sun protection; Ultraviolet exposure.

Figures

Fig. 1
Fig. 1
Study schematic

References

    1. American Cancer Society . Cancer facts and figures 2016. Atlanta: American Cancer Society; 2016.
    1. Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340(17):1341–1348. doi: 10.1056/NEJM199904293401707.
    1. Narayanan DL, Saladi RN, Fox JL. Ultraviolet radiation and skin cancer. Int J Dermatol. 2010;49(9):978–986. doi: 10.1111/j.1365-4632.2010.04474.x.
    1. Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol. 2010;146(3):265–272. doi: 10.1001/archdermatol.2010.2.
    1. Cruse CW, Wells KE, Schroer KR, Reintgen DS. Etiology and prognosis of local recurrence in malignant melanoma of the skin. Ann Plast Surg. 1992;28(1):26–28. doi: 10.1097/00000637-199201000-00009.
    1. Soong SJ, Harrison RA, McCarthy WH, Urist MM, Balch CM. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol. 1998;67(4):228–233. doi: 10.1002/(SICI)1096-9098(199804)67:4<228::AID-JSO4>;2-A.
    1. Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control. 2007;18(3):295–304. doi: 10.1007/s10552-006-0091-x.
    1. Lyons EJ, Lewis ZH, Mayrsohn BG, Rowland JL. Behavior change techniques implemented in electronic lifestyle activity monitors: a systematic content analysis. J Med Internet Res. 2014;16(8):e192. doi: 10.2196/jmir.3469.
    1. Cheatham SW, Stull KR, Fantigrassi M, Motel I. The efficacy of wearable activity tracking technology as part of a weight loss program: a systematic review. J Sports Med Phys Fitness. 2017;58(4):534–548.
    1. Mendoza JA, Baker KS, Moreno MA, Whitlock K, Abbey-Lambertz M, Waite A, et al. A Fitbit and Facebook mHealth intervention for promoting physical activity among adolescent and young adult childhood cancer survivors: a pilot study. Pediatr Blood Cancer. 2017. 10.1002/pbc.26660.
    1. Nguyen NH, Hadgraft NT, Moore MM, Rosenberg DE, Lynch C, Reeves MM, et al. A qualitative evaluation of breast cancer survivors’ acceptance of and preferences for consumer wearable technology activity trackers. Support Care Cancer. 2017;25:3375–3384. doi: 10.1007/s00520-017-3756-y.
    1. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM. The Fitbit one physical activity tracker in men with prostate cancer: validation study. JMIR Cancer. 2017;3(1):e5. doi: 10.2196/cancer.6935.
    1. Gell NM, Grover KW, Humble M, Sexton M, Dittus K. Efficacy, feasibility, and acceptability of a novel technology-based intervention to support physical activity in cancer survivors. Support Care Cancer. 2017;25(4):1291–1300. doi: 10.1007/s00520-016-3523-5.
    1. Glanz K, Schoenfeld ER, Steffen A. A randomized trial of tailored skin cancer prevention messages for adults: Project SCAPE. Am J Public Health. 2010;100(4):735–741. doi: 10.2105/AJPH.2008.155705.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Becker MH. The health belief model and personal health beahvior. Health Educ Monogr. 1974;2:324–508. doi: 10.1177/109019817400200401.
    1. Glanz K, Rimer BK, Viswanath K, editors. Health behavior: theory, research, and practice. 5. San Francisco: Jossey-Bass Public Health; 2015.
    1. Banerjee S, Hoch EG, Kaplan PD, Dumont EL. A comparative study of wearable ultraviolet radiometers. 2017 IEEE Life Sciences Conference (LSC); 2017: IEEE.
    1. Stump TK, Aspinwall LG, Gray EL, Xu S, Maganti N, Leachman SA, et al. Daily Minutes of Unprotected Sun Exposure (MUSE) inventory: measure description and comparisons to UVR sensor and sun protection survey data. Prev Med Rep. 2018;11:305–311. doi: 10.1016/j.pmedr.2018.07.010.
    1. Glanz K, Yaroch AL, Dancel M, Saraiya M, Crane LA, Buller DB, et al. Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. Arch Dermatol. 2008;144(2):217–222. doi: 10.1001/archdermatol.2007.46.
    1. Perna FM, Dwyer LA, Tesauro G, Taber JM, Norton WE, Hartman AM, et al. Research on skin cancer-related behaviors and outcomes in the NIH Grant portfolio, 2000-2014: skin cancer intervention across the cancer control continuum (SCI-3C) JAMA Dermatol. 2017;153(5):398–405. doi: 10.1001/jamadermatol.2016.6216.
    1. Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med. 2016;176(6):816–825. doi: 10.1001/jamainternmed.2016.1548.
    1. Holman DM, Berkowitz Z, Guy GP, Jr, Hartman AM, Perna FM. The association between demographic and behavioral characteristics and sunburn among U.S. adults - National Health Interview Survey, 2010. Prev Med. 2014;63:6–12. doi: 10.1016/j.ypmed.2014.02.018.
    1. Rat C, Quereux G, Riviere C, Clouet S, Senand R, Volteau C, et al. Targeted melanoma prevention intervention: a cluster randomized controlled trial. Ann Fam Med. 2014;12(1):21–28. doi: 10.1370/afm.1600.
    1. Vogel RI, Strayer LG, Ahmed RL, Blaes A, Lazovich D. A qualitative study of quality of life concerns following a melanoma diagnosis. J Skin Cancer. 2017;2017:2041872. doi: 10.1155/2017/2041872.
    1. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3):141–146.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Brooke JB. SUS - a quick and dirty usability scale. In: Jordan P, Thomas B, Weerdmeester B, McLelland I, editors. Usability evaluation in industry. London: Talyor and Francis; 1996.
    1. Vogel RI, Strayer LG, Engelman L, Nelson HH, Blaes AH, Anderson KE, et al. Sun exposure and protection behaviors among long-term melanoma survivors and population controls. Cancer Epidemiol Biomark Prev. 2017;26:607–613. doi: 10.1158/1055-9965.EPI-16-0854.
    1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613. doi: 10.1161/CIRCULATIONAHA.109.192703.
    1. Jordan AB, Bleakley A, Alber JM, Lazovich D, Glanz K. Developing and testing message strategies to reduce indoor tanning. Am J Health Behav. 2020;44(3):292–301. doi: 10.5993/AJHB.44.3.2.
    1. Fishbein M, Ajzen I. Predicting and changing behavior: the reasoned action approach. New York: Psychology Press; 2010.
    1. Blanchard C, Courneya K, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–2204. doi: 10.1200/JCO.2007.14.6217.
    1. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995;4(6):523–531. doi: 10.1007/BF00634747.
    1. Schafer JL. Analysis of incomplete multivariate data. New York: Chapman and Hall; 1997.
    1. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987.
    1. Molenberghs G, Kenward MG. Missing data in clinical studies. New York: Wiley; 2007.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj